Lamisil Singeldos (Terbinafine)

Terbinafine works by inhibiting the fungal enzyme squalene epoxidase, which is essential for the synthesis of ergosterol, a key component of fungal cell membranes. Blocking this step leads to an accumulation of toxic squalene and depletion of ergosterol, compromising membrane integrity and causing fungal cell death. Human cells lack this enzyme, giving terbinafine a high degree of selectivity for fungal organisms.

The appropriate dose of Lamisil Singeldos is determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and other clinical factors. The prescriber will specify the amount of product to apply, the frequency of application (often once or twice daily), and the duration of therapy, which typically ranges from one to several weeks.

Safety data for topical terbinafine during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Lamisil Singeldos. The prescriber may decide to avoid the medication or to monitor the patient closely, depending on the clinical situation.

To place an order for Lamisil Singeldos, visit the product page on the GNH India website (gnhindia.com) and submit an enquiry with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any necessary import documentation.

Lamisil Singeldos (terbinafine) belongs to the allylamine class of antifungals, which act by inhibiting squalene epoxidase, whereas azole antifungals such as clotrimazole or miconazole block lanosterol 14‑α‑demethylase. Terbinafine often requires a shorter treatment course and has a lower recurrence rate for dermatophyte infections, but individual response and tolerability may vary, making physician guidance essential when selecting therapy.

Lamisil Singeldos should be stored at room temperature, typically below 25 °C (77 °F). Keep the product in its original container, tightly closed, and protect it from moisture, direct sunlight and extreme heat. Do not freeze the medication. Follow any additional storage instructions on the label to maintain product stability and efficacy.

Lamisil Singeldos is applied directly to clean, dry skin or nails in the area affected by the fungal infection. The prescribed amount is spread thinly over the lesion and a small margin of surrounding healthy skin, usually once or twice daily as directed by the prescriber. Hands should be washed after application, and the treated area should be allowed to dry before covering with clothing or bandages.

Although most adverse reactions are mild and localized, serious risks can include severe allergic responses such as angioedema, generalized skin eruptions like Stevens‑Johnson syndrome, and, rarely, systemic hepatotoxicity resulting from significant absorption. Patients should seek immediate medical attention if they experience swelling of the face or throat, widespread rash, fever, jaundice, or persistent abdominal discomfort while using the product.

Lamisil Singeldos should be avoided in individuals with a known hypersensitivity to terbinafine or any of the formulation excipients. It is also contraindicated on extensive open wounds, severe burns, or damaged skin where absorption may be increased. Patients with pre‑existing liver disease, pregnant or nursing women, and those taking interacting medications should consult a healthcare professional before use.